Le marché des modèles pulmonaires in vitro était évalué à 405,4 millions USD en 2021 et devrait atteindre 1 194,4 millions USD d'ici 2031. Le marché devrait enregistrer un TCAC de 12,0 % entre 2023 et 2031. L'adoption croissante de modèles technologiquement avancés devrait rester l'une des principales tendances du marché des modèles pulmonaires in vitro.
Analyse de marché du modèle pulmonaire in vitro
Augmentation des troubles respiratoires
Les maladies respiratoires chroniques (MRC) sont la principale cause de décès et d'invalidité dans le monde. Les MRC comprennent la bronchopneumopathie chronique obstructive (BPCO), l'asthme et d'autres maladies respiratoires chroniques telles que les maladies pulmonaires professionnelles et l'hypertension pulmonaire. Selon les statistiques de l'Organisation panaméricaine de la santé (OPS) et de l'Organisation mondiale de la santé (OMS), les MRC sont responsables de 8,9 millions d'années de vie perdues (YLL) des deux sexes, dont 4,7 millions d'hommes et 4,2 millions de femmes. Par conséquent, pour contrôler le taux de mortalité des MRC, il existe une demande accélérée de modèles pulmonaires in vitro pour évaluer les MRC et concevoir une ligne de traitement (thérapeutique). Par exemple, un modèle 3D des voies respiratoires humaines (HRT) fournit des informations pertinentes qui peuvent être utilisées pour des études visant à mieux comprendre la biologie pulmonaire, la communication croisée entre les cellules immunitaires, les allergènes et les agents pathogènes en suspension dans l'air et l'administration de médicaments respiratoires. Ces modèles pulmonaires 3D in vitro innovants tenteront d'améliorer la réponse au traitement des maladies respiratoires chroniques au sein de la population, stimulant ainsi la croissance du marché au cours de la période 2021-2031.
Aperçu du marché des modèles pulmonaires in vitro
La technologie, l’innovation et les solutions technologiques intelligentes continuent d’influencer considérablement le marché des modèles pulmonaires in vitro. L’augmentation des troubles respiratoires et des médicaments de gestion et le modèle pulmonaire in vitro pour la fibrose pulmonaire sont les facteurs les plus influents responsables de la croissance du marché des modèles pulmonaires in vitro. Le modèle pulmonaire in vitro technologiquement avancé est une tendance clé pour la croissance du marché des modèles pulmonaires in vitro. Les modèles pulmonaires in vitro conçus offriront une opportunité de marché lucrative pour la croissance du marché des modèles pulmonaires in vitro.
Personnalisez ce rapport en fonction de vos besoins
Vous bénéficierez d'une personnalisation gratuite de n'importe quel rapport, y compris de certaines parties de ce rapport, d'une analyse au niveau des pays, d'un pack de données Excel, ainsi que de superbes offres et réductions pour les start-ups et les universités.
Marché des modèles pulmonaires in vitro : informations stratégiques
- Obtenez les principales tendances clés du marché de ce rapport.Cet échantillon GRATUIT comprendra une analyse de données, allant des tendances du marché aux estimations et prévisions.
Modèle pulmonaire in vitroMoteurs et opportunités du marché
Un modèle pulmonaire in vitro pour la fibrose pulmonaire devrait favoriser le marché
In-vivo lung models prove valuable as they identify specific cellular and molecular mechanisms that can trigger pulmonary disease and progression. For example, in-vitro models are not only accessible for studying the molecular mechanisms targeting pulmonary fibrosis but also for innovative drug applications for screening fibrosis. The most frequently used in-vitro models to study pulmonary fibrosis are 2D cell cultures. Currently, in-vitro lung models have been developed to improve preclinical drug testing and bridge the translational gap to human clinical trials as these techniques offer advanced imaging and analysis of disease mechanisms, allowing drug discovery for validation and personalized treatment. Therefore, innovative models and applications of in-vitro lung models will assist to develop effective treatment options to treat pulmonary fibrosis thereby dominating market growth.
Engineered In-Vitro Lung Models– An Opportunity
The development of engineered in-vitro lung models is still a growing research field. However, there are some physiologically relevant engineered human in-vitro models. These include 3D-tissue-engineered lung models to study the immune response following viral infections of the small airway. The 3D in-vitro lung model is a promising research field to study lower respiratory viruses. Also, such 3D in-vitro lung models can be more predictive in studying viral pathogenesis, treatment strategies, and utility experimental analysis or therapeutic clinical trials. Therefore, such innovative 3D in-vitro lung model will provide lucrative market opportunities will account considerable market share in the coming years for in-vitro lung model market.
In-Vitro Lung Model
Market Report Segmentation Analysis
Key segments that contributed to the derivation of the In-Vitro Lung Model Market analysis are candidature and services.
- Based on Type, the In-Vitro Lung Model Market is divided into 2D and 3D. The 3D segment may hold a larger market share in 2023.
- Based on Application, the In-Vitro Lung Model Market is segmented as drug screening, toxicology, 3d model development, physiological research, stem cell research, and regenerative medicine. The drug screening segment may hold a larger market share in 2023.
In-Vitro Lung Model Market Share Analysis by Geography
The geographic scope of the In-Vitro Lung ModelMarket report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
North America has dominated the In-Vitro Lung Model Market. In North America, US accounts considerable share for in-vitro lung model. Presence of top manufacturers present in the US, is one of the most influential factors responsible for market growth. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
In-Vitro Lung Model
In-Vitro Lung Model Market Regional Insights
The regional trends and factors influencing the In-Vitro Lung Model Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses In-Vitro Lung Model Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
- Get the Regional Specific Data for In-Vitro Lung Model Market
In-Vitro Lung Model Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 405.4 Million |
| Market Size by 2031 | US$ 1,194.4 Million |
| Global CAGR (2023 - 2031) | 12.0% |
| Historical Data | 2021-2022 |
| Forecast period | 2023-2031 |
| Segments Covered | By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
In-Vitro Lung Model Market Players Density: Understanding Its Impact on Business Dynamics
The In-Vitro Lung Model Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the In-Vitro Lung Model Market are:
- Epithelix Sarl
- MATTEK
- Lonza
- Insphero
- Emulate, Inc.
- AlveoliX AG
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the In-Vitro Lung Model Market top key players overview
In-Vitro Lung ModelMarket News and Recent Developments
The In-Vitro Lung ModelMarket is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in them market for In-Vitro Lung Model and strategies:
- En décembre 2021, Lonza a annoncé une collaboration avec Agilent Technologies Inc. et le développement de technologies analytiques innovantes avec la « plateforme Cocoon de Lonza ». Le partenariat vise à faire progresser l'intégration de méthodes analytiques existantes et nouvelles pour fabriquer des flux de travail de thérapies cellulaires à l'échelle du patient à l'aide de la plateforme Cocoon. Par conséquent, grâce à la collaboration, les entreprises progresseront dans la création de technologies et de solutions durables améliorant la disponibilité de thérapies cellulaires cruciales pour diverses maladies pulmonaires.
Rapport de marché sur le modèle pulmonaire in vitro et livrables
Le rapport « Taille du marché et prévisions du modèle pulmonaire in vitro (2021-2031) » fournit une analyse détaillée du marché couvrant les domaines ci-dessous :
- Taille du marché et prévisions aux niveaux mondial, régional et national pour tous les segments de marché clés couverts par le périmètre
- Dynamique du marché, comme les facteurs moteurs, les contraintes et les opportunités clés
- Principales tendances futures
- Analyse détaillée des cinq forces de PEST/Porter et SWOT
- Analyse du marché mondial et régional couvrant les principales tendances du marché, les principaux acteurs, les réglementations et les développements récents du marché
- Analyse du paysage industriel et de la concurrence couvrant la concentration du marché, l'analyse de la carte thermique, les principaux acteurs et les développements récents
- Profils d'entreprise détaillés
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For